Maternal Rh D status, anti-D immune globulin exposure during pregnancy, and risk of autism spectrum disorders

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 3, 2008, Pages 234.e1-234.e6

  Croen, Lisa A ^a   Matevia, Marilyn ^a   Yoshida, Cathleen K ^a   Grether, Judith K ^b  

^a DIVISION OF RESEARCH   (United States)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

autism spectrum disorders; perinatal risk factors; RhoGam; thimerosal

Indexed keywords

RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ADULT; ARTICLE; AUTISM; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGENY; RANDOMIZATION; RISK FACTOR; UNITED STATES;

EID: 50349089539     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.04.044     Document Type: Article

References (32)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fourth ed. (1994), American Psychiatric Association, Washington (DC)
2. Veenstra-Vander Weele J., Christian S.L., and Cook Jr. E.H. Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 5 (2004) 379-405
3. Fombonne E. Epidemiological trends in rates of autism. Mol Psychiatry 7 Suppl 2 (2002) S4-S6
4. Lawler C.P., Croen L.A., Grether J.K., and Van de Water J. Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev 10 (2004) 292-302
5. Ball L.K., Ball R., and Pratt R.D. An assessment of thimerosal use in childhood vaccines. Pediatrics 107 (2001) 1147-1154
6. Grandjean P., Weihe P., White R.F., et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 19 (1997) 417-428
7. Davidson P.W., Myers G.J., Cox C., et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 280 (1998) 701-707
8. Bernard S. Association between thimerosal-containing vaccine and autism. JAMA 291 (2004) 180-181
9. Blaxill M.F., Redwood L., and Bernard S. Thimerosal and autism?. A plausible hypothesis that should not be dismissed. Med Hypotheses 62 (2004) 788-794
10. Mercer L., Creighton S., Holden J.J., and Lewis M.E. Parental perspectives on the causes of an autism spectrum disorder in their children. J Genet Couns 15 (2006) 41-50
11. Hviid A., Stellfeld M., Wohlfahrt J., and Melbye M. Association between thimerosal-containing vaccine and autism. JAMA 290 (2003) 1763-1766
12. Madsen K.M., Lauritsen M.B., Pedersen C.B., et al. Thimerosal and the occurrence of autism: Negative ecological evidence from Danish population-based data. Pediatrics 112 3 Pt 1 (2003) 604-606
13. Fombonne E., Zakarian R., Bennett A., Meng L., and McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: Prevalence and links with immunizations. Pediatrics 118 (2006) e139-e150
14. Schechter R., and Grether J. Continuing increases in autism reported to California's Developmental Services System: Mercury in retrograde. Arch Gen Psychiatry 65 (2008) 19-24
15. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology. Int J Gynaecol Obstet 66 (1999) 63-70
16. Food and Drug Administration Center for Biologics Evaluation and Research. Thimerosal, Mercury in Plasma Derived Products. http://www.fda.gov/cber/vaccine/thimerosal.htm Accessed Nov. 20, 2007
17. Krieger N. Overcoming the absence of socioeconomic data in medical records: Validation and application of a census-based methodology. Am J Public Health 82 (1992) 703-710
18. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) (1999), Practice Management Information Corp, Los Angeles (CA)
19. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., and Van de Water J. Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: A case-control study. Arch Pediatr Adolesc Med 159 (2005) 151-157
20. Croen L.A., Yoshida C.K., Odouli R., and Newman T.B. Neonatal hyperbilirubinemia and risk of autism spectrum disorders. Pediatrics 115 (2005) e135-e138
21. Rosen N.J., Yoshida C.K., and Croen L.A. Infection in the first 2 years of life and autism spectrum disorders. Pediatrics 119 (2007) e61-e69
22. ACOG Practice Bulletin No. 75. Management of alloimmunization. Obstet Gynecol 108 (2006) 457-464
23. Miles J.H., and Takahashi T.N. Lack of association between Rh status, Rh immune globulin in pregnancy and autism. Am J Med Genet A 143A (2007) 1397-1407
24. Thompson W.W., Price C., Goodson B., et al. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years. N Engl J Med 357 (2007) 1281-1292
25. Holmes A.S., Blaxill M.F., and Haley B.E. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22 (2003) 277-285
26. Geier D.A., and Geier M.R. A prospective study of thimerosal-containing Rho(D)- immune globulin administration as a risk factor for autistic disorders. J Matern Fetal Neonatal Med 20 (2007) 385-390
27. Lord C., Rutter M., and Le Couteur A. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24 (1994) 659-685
28. Lord C., Risi S., Lambrecht L., et al. The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 30 (2000) 205-223
29. American Psychiatric Association, and Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV-TR (2000), American Psychiatric Association, Washington (DC)
30. Mason-Brothers A., Ritvo E.R., Pingree C., et al. The UCLA-University of Utah epidemiologic survey on autism: prenatal, perinatal, and postnatal factors. Pediatrics 86 (1990) 514-519
31. Juul-Dam N., Townsend J., and Courchesne E. Prenatal, perinatal, and neonatal factors in autism, pervasive developmental disorder-not otherwise specified, and the general population. Pediatrics 107 (2001) E63
32. Zandi P.P., Kalaydjian A., Avramopoulos D., Shao H., Fallin M.D., and Newschaffer C.J. Rh and ABO maternal-fetal incompatibility and risk of autism. Am J Med Genet B Neuropsychiatr Genet 141 (2006) 643-647